Nurse Practitioner, Family · Hagerstown, MD
NPI
1295279214
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
11110 Medical Campus Rd
Hagerstown, MD, 21742
Phone (301) 714-4444
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
156 services
Medicare patients, 2024
37
Average age 55
Drug cost, 2024
$278K
539 prescriptions
Company payments, 2025
$3,765
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sheri L Denham was code 99214 (office e&m - established), 127 times for 30 patients. In total Sheri L Denham billed 156 services in 4 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 127 | 30 | $81.73 | $10K |
| 99204 Office E&M - New | Office | 17 | 17 | $93.36 | $1,587 |
By year: 2023 $13K for 164 services; 2024 $13K for 156 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sheri L Denham prescribed most often to Medicare patients was Sublocade (Buprenorphine), with 51 prescriptions and refills. In total Sheri L Denham wrote 539 Medicare prescriptions that cost $278K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sublocade Buprenorphine | 51 | 51 | 19 | $107K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 47 | 47 | 18 | $5,287 |
| Quetiapine Fumarate Generic | 38 | 38 | Under 11 | $271 |
| Buprenorphine Hcl Generic | 27 | 27 | Under 11 | $466 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 27 | 27 | Under 11 | $9,488 |
| Brixadi Buprenorphine | 19 | 19 | Under 11 | $34K |
| Vivitrol Naltrexone Microspheres | 18 | 18 | Under 11 | $31K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 16 | 16 | Under 11 | $243 |
| Topiramate Generic | 16 | 24 | 12 | $65.09 |
| Ozempic Semaglutide | 14 | 18 | Under 11 | $17K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 12 | 18 | Under 11 | $130 |
| Risperidone Generic | 11 | 11 | Under 11 | $18.15 |
Brand drugs: 172 claims; generic drugs: 350 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sheri L Denham $3,765 ($3,765 in general payments such as food, travel and fees) from 12 companies. The largest payer was Indivior Inc. with $2,897.
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. INDV | 11 | $2,897 |
| Abbvie Inc. ABBV | 12 | $215 |
| Braeburn Inc. | 7 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $116 |
| Novo Nordisk Inc NVO | 4 | $98.82 |
| Alkermes, Inc. ALKS | 4 | $80.41 |
| Lundbeck LLC | 3 | $67.94 |
| Lilly USA, LLC LLY | 2 | $45.24 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $42.82 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $25.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.